Intrinsic Value of S&P & Nasdaq Contact Us

IQVIA Holdings Inc. IQV NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
60/100
3/7 Pass
SharesGrow Intrinsic Value
$294.48
+68%
Analyst Price Target
$233.80
+33.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

IQVIA Holdings Inc. (IQV) trades at a trailing P/E of 21.2, forward P/E of 13.8. Trailing earnings yield is 4.72%, forward earnings yield 7.25%. PEG 4.51. Graham Number is $83.79.

Criteria proven by this page:

  • VALUE (63/100, Pass) — P/E is below market average (21.2); analyst target implies upside (+33.4%); earnings yield beats bond yields (4.72%).
  • Forward P/E 13.8 (down from trailing 21.2) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 4.51 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 4.72% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 7.25% as earnings recover.
  • Analyst consensus target $233.80 (+33.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 60/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
60/100
SG Score
View full scorecard →
VALUE
63/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
48/100
→ Income
~
GROWTH
55/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — IQV

Valuation Multiples
P/E (TTM)21.2
Forward P/E13.8
PEG Ratio4.51
Forward PEG0.22
P/B Ratio4.43
P/S Ratio1.76
EV/EBITDA12.4
Per Share Data
EPS (TTM)$8.00
Forward EPS (Est.)$12.70
Book Value / Share$39.00
Revenue / Share$95.94
FCF / Share$14.59
Yields & Fair Value
Earnings Yield4.72%
Forward Earnings Yield7.25%
Dividend Yield0.00%
Graham Number$83.79
SharesGrow IV$294.48 (+68%)
Analyst Target$233.80 (+33.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 98.6 -1.31 1.31 1.66 -
2017 16.3 0.02 2.63 2.20 -
2018 91.4 -1.16 3.52 2.27 -
2019 157.8 -6.91 5.02 2.72 -
2020 122.9 2.51 5.71 3.02 -
2021 55.9 0.23 8.94 3.89 -
2022 35.2 2.31 6.67 2.67 -
2023 31.3 1.16 6.96 2.84 -
2024 25.9 10.65 5.87 2.31 -
2025 28.5 6.34 5.96 2.38 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.76 $6.88B $115M 1.7%
2017 $5.88 $9.74B $1.31B 13.4%
2018 $1.24 $10.41B $259M 2.5%
2019 $0.96 $11.09B $191M 1.7%
2020 $1.43 $11.36B $279M 2.5%
2021 $4.95 $13.87B $966M 7%
2022 $5.72 $14.41B $1.09B 7.6%
2023 $7.29 $14.98B $1.36B 9.1%
2024 $7.49 $15.41B $1.37B 8.9%
2025 $7.84 $16.31B $1.36B 8.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $12.70 $12.49 – $13.09 $17.24B $17.19B – $17.33B 15
2027 $14.08 $13.54 – $14.73 $18.24B $17.84B – $18.74B 15
2028 $15.69 $13.05 – $18.67 $19.33B $19.32B – $19.34B 8
2029 $17.63 $17.39 – $18.00 $20.57B $20.36B – $20.89B 6
2030 $19.50 $19.24 – $19.91 $21.76B $21.54B – $22.11B 6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message